Research
Print page Print page
Switch language
The Capital Region of Denmark - a part of Copenhagen University Hospital
Published

The Danish severe asthma register: an electronic platform for severe asthma management and research

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Automatic oxygen titration with O2matic® to patients admitted with COVID-19 and hypoxemic respiratory failure

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Disease self-management in patients with moderate COPD: a thematic analysis

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Guideline for the management of COVID-19 patients during hospital admission in a non-intensive care setting

    Research output: Contribution to journalReviewResearchpeer-review

  4. Clinical and daily respiratory care and clinical trials within the COVID-19 era

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Clinical characteristics of the BREATHE cohort - a real-life study on patients with asthma and COPD

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. Antibiotics during childhood and development of appendicitis-a nationwide cohort study

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Anti-alarmins in asthma: targeting the airway epithelium with next-generation biologics

    Research output: Contribution to journalReviewResearchpeer-review

View graph of relations

The evaluation and management of severe asthma patients require collection of comprehensive information, which is often a challenge in a busy outpatient clinic. The Danish Severe Asthma Register (DSAR) was designed as an electronic patient record form that captures operational clinical data and provides a clinical overview of the severe asthma patient. DSAR is a nationwide register; all patients in Denmark who are treated with biologics for severe asthma are included, and data are as a minimum entered at start of biological treatment, after four and 12 months of treatment, and hereafter annually. Currently, there are data from 621 treatment courses with biologics included in DSAR, with 71% of patients treated with anti-IL-5 drugs and 29% with an anti-IgE drug. Patients enter Patient Reported Outcome Measures electronically on tablets when they arrive in the outpatient clinic and their answers are immediately available to the clinician during the consultation. Nurses and doctors enter clinical data into DSAR during the consultation. DSAR offers immediate access to well-presented longitudinal overview and automatically creates a journal output that can be copy-pasted into the hospital's existing health record form. DSAR is also currently expanding with an app, to be used for monitoring of home-treatment. In addition to serving as an electronic patient record form, DSAR will also provide opportunities to monitor the real-life efficacy of biological treatment for severe asthma in Denmark, and it will be a valuable research platform that will aid in answering important research questions on severe asthma in the future.

Original languageEnglish
JournalEuropean Clinical Respiratory Journal
Volume8
Issue number1
Pages (from-to)1842117
ISSN2001-8525
DOIs
Publication statusPublished - 2 Nov 2020

ID: 61308276